Vox Afflictorum (@psychwithdrawal) 's Twitter Profile
Vox Afflictorum

@psychwithdrawal

Psychiatry, philosophy, informed consent, patient advocacy, prescribed harm.

ID: 1918391969342210048

calendar_today02-05-2025 19:48:29

30 Tweet

29 Followers

68 Following

Antidepressant Coalition for Education (@ace_coalitioned) 's Twitter Profile Photo

‼️All hands on deck‼️ The petition now has an official docket number — it’s live in the FDA system and ready for public comment! Add your comment here: regulations.gov/commenton/FDA-… This is a critical next step.

‼️All hands on deck‼️

The petition now has an official docket number — it’s live in the FDA system and ready for public comment! Add your comment here: regulations.gov/commenton/FDA-…

This is a critical next step.
Vox Afflictorum (@psychwithdrawal) 's Twitter Profile Photo

This piece explores two major blows to modern psychiatry: the re-analysis of the STAR*D antidepressant trial and the review debunking the serotonin theory of depression, set against today's political backdrop.

Antidepressant Coalition for Education (@ace_coalitioned) 's Twitter Profile Photo

We have 180 days. That’s how long the FDA has to respond to our petition. That gives us 180 days to flood the system with MedWatch reports—to show that antidepressant withdrawal is a serious, under-recognized risk that must be reflected in updated prescribing information.

We have 180 days.

That’s how long the FDA has to respond to our petition. That gives us 180 days to flood the system with MedWatch reports—to show that antidepressant withdrawal is a serious, under-recognized risk that must be reflected in updated prescribing information.
Medicating Normal (@medicatingnorm1) 's Twitter Profile Photo

Dr. Mark Horowitz, co-author of "The Maudsley Deprescribing Guidelines," & co-founder of the virtual tapering clinic, Outro Health , along w/ Morgan Stewart, founder of Antidepressant Coalition for Education , are featured in this article. ARTICLE LINK: webmd.com/depression/fea…

Psychotropic Deprescribing Council (@psychotropicdc) 's Twitter Profile Photo

When psychiatric drug treatment comes to an end, how may a clinician minimize the risk of withdrawal symptoms or relapse while #deprescribing? Free webinar Friday, June 27, 2025. RSVP today! psychdeprescribing.org/index.php/2025…

When psychiatric drug treatment comes to an end, how may a clinician minimize the risk of withdrawal symptoms or relapse while #deprescribing?  

Free webinar Friday, June 27, 2025. RSVP today! psychdeprescribing.org/index.php/2025…
Vox Afflictorum (@psychwithdrawal) 's Twitter Profile Photo

Level-headed coverage of the misleading JAMA Psychiatry review authored by Kalfas et al. including push-back from Dr John Read and Awais Aftab, highlighting the dangers of downplaying the clinical significance of antidepressant withdrawal. npr.org/2025/07/13/nx-…

Vox Afflictorum (@psychwithdrawal) 's Twitter Profile Photo

The psychiatry aided part is particularly interesting - this 1997 paper is likely one of the originating sources of the nomenclature, sponsored by "an unrestricted educational grant from Eli Lilly and Company" when they were still called "SRIs". psychiatrist.com/pdf/serotonin-…

Vox Afflictorum (@psychwithdrawal) 's Twitter Profile Photo

One of psychiatry's most egregious missteps: Simultaneously acknowledging debilitating side effects from psych drugs exist while coming to conclusions like "meteorological variables seem to have an influence in the course of bipolar disorder, especially temperature and sunlight"